Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

TCT 646: Percutaneous Tricuspid Valve-in-Valve Implantation in Failed Surgical Bioprosthetic Valves - Brazilian Single Center Registry

Presenter: Filippe Filippini

October 25, 2023

Presentation TCT 2023

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Presenter: Aneeza Jamshed

October 25, 2023

Presentation TCT 2023

Position 2: Initial SAVR With Bioprosthetic Valve/Ross

Presenter: S. Chris Malaisrie

October 25, 2023

Presentation TCT 2023

TCT 710: Valve-in-Valve Transcatheter Aortic Valve Replacement in Failed Trifecta Bioprosthetic Aortic Valve

Presenter: Shivabalan Kathavarayan Ramu

October 25, 2023

Presentation TCT 2023

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Presenter: Michael Reardon

October 25, 2023

Presentation TCT 2023

TCT 520: Impact of Ballon Dilatation in ViV-TAVR according to Bioprosthetic Aortic Valve Type.

Presenter: Athanasios Koutsoukis

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2023

TCT 772: Transcatheter Electrosurgical Leaflet Splitting to Prevent TAVR-induced Coronary Obstruction in Stented vs. Stentless Bioprosthetic Aortic Valves: Results From the Multicenter EURO-BASILICA Registry

Presenter: Ines Richter

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

Presenter: Yousef Darestani

October 24, 2023

Video

» Live Case

Saint Lukes Mid-America Heart Institute, Kansas City, MO - Valve - In -Valve TAVR + Bioprosthetic Valve Fracture

October 25, 2023

Advertisement

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCT 646: Percutaneous Tricuspid Valve-in-Valve Implantation in Failed Surgical Bioprosthetic Valves - Brazilian Single Center Registry

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Position 2: Initial SAVR With Bioprosthetic Valve/Ross

TCT 710: Valve-in-Valve Transcatheter Aortic Valve Replacement in Failed Trifecta Bioprosthetic Aortic Valve

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

TCT 520: Impact of Ballon Dilatation in ViV-TAVR according to Bioprosthetic Aortic Valve Type.

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 772: Transcatheter Electrosurgical Leaflet Splitting to Prevent TAVR-induced Coronary Obstruction in Stented vs. Stentless Bioprosthetic Aortic Valves: Results From the Multicenter EURO-BASILICA Registry

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

Saint Lukes Mid-America Heart Institute, Kansas City, MO - Valve - In -Valve TAVR + Bioprosthetic Valve Fracture

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content